While the Canadian Cardiovascular Society’s lipid guidelines recommend a once in a lifetime testing of Lp(a), there are no approved agents for lowering Lp(a) levels.
Low-dose ASA should not be routinely prescribed for the primary prevention of stroke, particularly in older persons predisposed to head trauma from falls.